ACELRX PHARMACEUTICALS INC sec form 4 filings insider trading, stock buying and selling. AcelRx Pharmaceuticals (ACRX) insider trading | wallmine On average, AcelRx Pharmaceuticals executives and independent directors trade stock every 46 days with the average trade being worth of $201,924. The most recent stock trade was executed by Mark G Edwards on 12 November 2019, trading 25,000 units of ACRX stock currently worth $44,500.

Insider Trading for AcelRx Pharmaceuticals Inc WhaleWisdom tracks 13F, Schedule 13D, and 13G EDGAR filings by hedge funds. Hedge Fund Whale Backtesting and search tools Insider Trade - Acrx' Insider Stock Buys and Sells ... Discover Acrx insider trade secrets and trading strategies of corporate insiders. Provides CEO, CFO, Director and Chief Executives trade reports, independent equity research, and stock screening. Insider trading history of Edwards Mark G at Acelrx ... The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Edwards Mark G since year 2005. The trader's CIK number is 1190429.At the time of the last reporting, Edwards Mark G was the Director of Acelrx Pharmaceuticals Inc .

ACRX: AcelRx Pharmaceuticals, Inc. - Insider Transactions Get the latest Insider Transactions for AcelRx Pharmaceuticals, Inc. from Zacks Investment Research every single Zacks Ranked stock

ACRX Insider Trading - ACELRX PHARMACEUTICALS INC - Form 4 ... ACELRX PHARMACEUTICALS INC sec form 4 filings insider trading, stock buying and selling. AcelRx Pharmaceuticals (ACRX) insider trading | wallmine On average, AcelRx Pharmaceuticals executives and independent directors trade stock every 46 days with the average trade being worth of $201,924. The most recent stock trade was executed by Mark G Edwards on 12 November 2019, trading 25,000 units of ACRX stock currently worth $44,500. AcelRx Pharmaceuticals (NASDAQ:ACRX) Insider Trades | Benzinga

AcelRx Pharmaceuticals, Inc. (ACRX) Stock Insiders Hit the ...

ACRX / AcelRx Pharmaceuticals, Inc. - Insider Trading and Ownership - SEC Form Common Stock Shares Outstanding, 79,573,001 shares (as of 2019-09- 30). Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Acelrx Pharmaceuticals Inc (ACRX) since 2005 are illustrated in  Get the latest insider transactions for AcelRx Pharmaceuticals, Inc. (ACRX). Find out the total of insider shares held, purchased and sold. Mar 9, 2020 NasdaqGM:ACRX Recent Insider Trading, March 9th 2020. AcelRx Pharmaceuticals is not the only stock that insiders are buying. For those  Insider Trading Alert - STFC, ACRX And CSC Traded By Insiders · By James Giaquinto. Apr 24, 2015 10:30 AM EDT. Why Portola Pharmaceuticals (PTLA) Stock  ACRX Stock Institutional Ownership and Insider Ownership - AcelRx Pharmaceuticals : the historical trend of stock ownership among institutions and insiders. and Earn $50 · 7-Day Free Trial. NAS:ACRX (USA) Also Trade In: Germany 

ACRX AcelRx Pharmaceuticals, Inc. Stock Quote

AcelRx Pharmaceuticals (NasdaqGM:ACRX) - Share price, News ... AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain.

Company profile for AcelRx Pharmaceuticals Inc. including key executives, insider trading, ownership, revenue and average growth rates. View detailed ACRX description & address.

ACRX: Get the latest AcelRx Pharmaceuticals stock price and detailed information including ACRX news, historical charts and realtime prices. Insider Trading Activities at Acelrx Pharmaceuticals Inc ... 42 rows · Company List - A; ACRX; Insider Trading activities of Acelrx Pharmaceuticals Inc (ACRX) . … AcelRx Pharmaceuticals, Inc. - TheStreet Insider Trading Alert - LAD, RSE And ACRX Traded By Insiders. By TheStreet Wire. May 8, 2015 12:15 PM EDT. (ACRX) Stock Tanks Today on FDA Demand For Further Zalviso Trials. By Tony Owusu. Acelrx Pharmaceuticals Inc (ACRX) - Insider Monkey

Insider Activity for Investors: AcelRx Pharmaceuticals ...